S. 2355 · 119th Congress · Health

Patients Deserve Price Tags Act

Requires healthcare providers to disclose prices to patients before delivering services. AI-read

Out of committee31k words Introduced Jul 17, 2025 · Latest action Jul 27, 2026

How far it has goneStage 3 of 6
  1. IntroducedJul 17, 2025 Done
  2. CommitteeReported Jul 27, 2026 Done
  3. Senate floorAwaiting vote Current stage
  4. House floorNot yet Not reached yet
  5. Chambers agreeNot yet Not reached yet
  6. PresidentNot yet Not reached yet

What it does

The Congressional Research Service hasn’t published a summary of this bill. Read the full text on Congress.gov.

Who lobbies on it

37 organizations, more than 99% of Senate bills · 134 filings, incl. 9 naming only H.R. 5582 · Q3 2025–Q3 2026

These 37 organizations’ PACs gave $391K to 17 of the 24 members sponsoring or cosponsoring S. 2355 in the 2025–26 election cycle.

See who got it, from which PACs, and how they compare to the rest of the Senate → Pro

One square per quarter since introduction, oldest left. Filled = named S. 2355 or H.R. 5582 that quarter.

  1. America's Health Insurance Plans Inc (ahip) 5 of 5 quarters
    “…H.R. 5582 - Patients Deserve Price Tags Act - Rep. James, John - Hospital and insurer price transparency requirement H.R. 6171 - ACA Copay CAP Act of 2025 - Rep. Auchincloss, Jake - establish out of pocket limit on prescription drugs H.R. 6248 - Healthy Competition for Better Care Act - Rep. Arrington, Jodey - ban…”

    $11.3M lobbying spend in 2026 to date, all issuesQ3 2026 filing · names both

  2. Cambia Health Solutions 5 of 5 quarters
    “…Price Transparency (S. 2355, H.R. 9393, H.R. 9397, H.R. 9645, H.R. 9390), Prior Authorization (H.R. 9396), 340B, Insulin (S. 4189), Corporate Practice of Medicine, Anticompetitive Contracting (H.R. 6248, S. 4027).”

    $2.0M lobbying spend in 2026 to date, all issuesQ3 2026 filing

  3. Laboratory Corporation of America Holdings 5 of 5 quarters
    “…H.R. 5582/S. 2355, the Patients Deserve Price Tags Act, H.R. 9393, the Lower Costs, More Transparency Act, and H.R. 9645, the Health Care Price Certainty for All Americans Act, provisions relating to lab test price transparency; Federal policy relating to supply chain issues affecting pre-clinical biomedical research…”

    $1.4M lobbying spend in 2026 to date, all issuesQ3 2026 filing · names both

34 more organizations, every filingPROUpgrade

Organizations that named S. 2355 or its companion H.R. 5582 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. Reports naming only H.R. 5582 are included and tagged. “Gave to” means the organization’s PAC gave to the member’s campaign in the 2025–26 cycle, net of refunds; it doesn’t mean the money was about this bill. Members sponsoring the companion, H.R. 5582, are counted on that bill’s page, not here. Organizations may lobby for, against, or to change a bill; filings don’t say which. Source: Senate lobbying disclosures (LD-2) from lda.gov; PAC gifts from FEC filings; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.

Actions

6 actions · newest first
  1. Jul 27, 2026Placed on Senate Legislative Calendar under General Orders. Calendar No. 522.
  2. Jul 27, 2026Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute. Without written report.
  3. Jul 22, 2026Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
  4. Mar 19, 2026Committee on Health, Education, Labor, and Pensions. Hearings held.
Show all 6 actionsShow fewer
  1. Jul 17, 2025Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  2. Jul 17, 2025Introduced in Senate